Table of Contents
Journal of Oral Oncology
Volume 2013 (2013), Article ID 519312, 13 pages
http://dx.doi.org/10.1155/2013/519312
Review Article

The Outline of Prognosis and New Advances in Diagnosis of Oral Squamous Cell Carcinoma (OSCC): Review of the Literature

Taibah University, P.O. Box 40361, Almadinah 41499, Saudi Arabia

Received 7 May 2013; Accepted 12 July 2013

Academic Editor: Shun-Fa Yang

Copyright © 2013 Esam Ahmad Omar. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. L. Parker, T. Tong, S. Bolden, and P. A. Wingo, “Cancer statistics, 1996,” Ca-A Cancer Journal for Clinicians, vol. 46, no. 1, pp. 5–27, 1996. View at Google Scholar · View at Scopus
  2. G. E. Laramore, C. B. Scott, M. Al-Sarraf et al., “Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on intergroup study 0034,” International Journal of Radiation Oncology Biology Physics, vol. 23, no. 4, pp. 705–713, 1992. View at Google Scholar · View at Scopus
  3. S. Petti, M. Masood, G. A. Messano, and C. Scully, “Alcohol is not a risk factor for oral cancer in nonsmoking, betel quid non-chewing individuals. A meta-analysis update,” Annali Di Igiene, vol. 25, no. 1, pp. 3–14, 2013. View at Google Scholar
  4. C.-C. Su and H.-C. Ho, “Neck mass with epithelial papillae: a diagnostic pitfall in aspiration cytology,” Otolaryngology—Head and Neck Surgery, vol. 137, no. 6, pp. 979–980, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Rodu and C. Jansson, “Smokeless tobacco and oral cancer: a review of the risks and determinants,” Critical Reviews in Oral Biology and Medicine, vol. 15, no. 5, pp. 252–263, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Warnakulasuriya, “Smokeless tobacco and oral cancer,” Oral Diseases, vol. 10, no. 1, pp. 1–4, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Scully, “Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission,” Oral Oncology, vol. 38, no. 3, pp. 227–234, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. S. R. Mallery, G. D. Stoner, P. E. Larsen et al., “Formulation and in-vitro and in-vivo evaluation of a mucoadhesive gel containing freeze dried black raspberries: implications for oral cancer chemoprevention,” Pharmaceutical Research, vol. 24, no. 4, pp. 728–737, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Boyle, “Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996,” Lung Cancer, vol. 17, no. 1, pp. 1–60, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. C. la Vecchia, R. Pagano, and A. Decarli, “Smoking prevalence in younger Italians,” Tobacco Control, vol. 5, no. 3, pp. 231–232, 1996. View at Google Scholar · View at Scopus
  11. D. V. Kleinman, P. A. Swango, J. J. Pindborg, and P. Gupta, “Toward assessing trends in oral mucosal lesions: lessons learned from oral cancer,” Advances in Dental Research, vol. 7, no. 1, pp. 32–41, 1993. View at Google Scholar · View at Scopus
  12. D. V. Kleinman, P. A. Swango, and J. J. Pindborg, “Epidemiology of oral mucosal lesions in United States schoolchildren: 1986-87,” Community Dentistry and Oral Epidemiology, vol. 22, no. 4, pp. 243–253, 1994. View at Google Scholar · View at Scopus
  13. S. G. Patel and J. P. Shah, “TNM staging of cancers of the head and neck: striving for uniformity among diversity,” Ca-A Cancer Journal for Clinicians, vol. 55, no. 4, pp. 242–258, 2005. View at Google Scholar · View at Scopus
  14. C. Scully and R. Bedi, “Ethnicity and oral cancer,” The Lancet Oncology, vol. 1, no. 1, pp. 37–42, 2000. View at Google Scholar · View at Scopus
  15. C. Scully and J. Bagan, “Oral squamous cell carcinoma overview,” Oral Oncology, vol. 45, no. 4-5, pp. 301–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. A. Woolgar, “Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma,” Oral Oncology, vol. 42, no. 3, pp. 229–239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Noguchi, H. Kinjyo, G.-I. Kohama, and K. Nakamori, “Invasive front in oral squamous cell carcinoma: image and flow cytometric analysis with clinicopathologic correlation,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 93, no. 6, pp. 682–687, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Garzino-Demo, A. Dell'Acqua, P. Dalmasso et al., “Clinicopathological parameters and outcome of 245 patients operated for oral squamous cell carcinoma,” Journal of Cranio-Maxillofacial Surgery, vol. 34, no. 6, pp. 344–350, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. M. Urist, C. J. O'Brien, S.-J. Soong, D. W. Visscher, and W. A. Maddox, “Squamous cell carcinoma of the buccal mucosa: analysis of prognostic factors,” American Journal of Surgery, vol. 154, no. 4, pp. 411–414, 1987. View at Google Scholar · View at Scopus
  20. A. R. Shaha, R. H. Spiro, J. P. Shah, and E. W. Strong, “Squamous carcinoma of the floor of the mouth,” American Journal of Surgery, vol. 148, no. 4, pp. 455–459, 1984. View at Google Scholar · View at Scopus
  21. H. Platz, R. Fries, M. Hudec, A. M. Tjoa, and R. R. Wagner, “The prognostic relevance of various factors at the time of the first admission of the patient. Retrospective DOSAK study on carcinoma of the oral cavity,” Journal of Maxillofacial Surgery, vol. 11, no. 1, pp. 3–12, 1983. View at Google Scholar · View at Scopus
  22. J. D. Crissman, W. Y. Liu, J. L. Gluckman, and G. Cummings, “Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx,” Cancer, vol. 54, no. 12, pp. 2995–3001, 1984. View at Google Scholar · View at Scopus
  23. C. Moore, J. G. Kuhns, and R. A. Greenberg, “Thickness as prognostic aid in upper aerodigestive tract cancer,” Archives of Surgery, vol. 121, no. 12, pp. 1410–1414, 1986. View at Google Scholar · View at Scopus
  24. C. M. Bier-Laning, R. Durazo-Arvizu, K. Muzaffar, and G. J. Petruzzelli, “Primary tumor thickness as a risk factor for Contralateral cervical metastases in T1/T2 oral tongue squamous cell carcinoma,” Laryngoscope, vol. 119, no. 5, pp. 883–888, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Fukano, H. Matsuura, Y. Hasegawa, and S. Nakamura, “Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma,” Head & Neck, vol. 19, no. 3, pp. 205–210, 1997. View at Google Scholar · View at Scopus
  26. C. T. Lwin, R. Hanlon, D. Lowe et al., “Accuracy of MRI in prediction of tumour thickness and nodal stage in oral squamous cell carcinoma,” Oral Oncology, vol. 48, no. 2, pp. 149–154, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J. F. Teichgraeber and A. A. Clairmont, “The incidence of occult metastases for cancer of the oral tongue and floor of the mouth: treatment rationale,” Head & Neck Surgery, vol. 7, no. 1, pp. 15–21, 1984. View at Google Scholar · View at Scopus
  28. H. Keski-Säntti, T. Atula, J. Törnwall, P. Koivunen, and A. Mäkitie, “Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue,” Oral Oncology, vol. 42, no. 1, pp. 96–101, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. K. H. Calhoun, P. Fulmer, R. Weiss, and J. A. Hokanson, “Distant metastases from head and neck squamous cell carcinomas,” Laryngoscope, vol. 104, no. 10, pp. 1199–1205, 1994. View at Google Scholar · View at Scopus
  30. D. Kademani, R. B. Bell, S. Bagheri et al., “Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade,” Journal of Oral and Maxillofacial Surgery, vol. 63, no. 11, pp. 1599–1605, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Haberal, H. Çelik, H. Göçmen, H. Akmansu, M. Yörük, and C. Özeri, “Which is important in the evaluation of metastatic lymph nodes in head and neck cancer: palpation, ultrasonography, or computed tomography?” Otolaryngology—Head and Neck Surgery, vol. 130, no. 2, pp. 197–201, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Esen, “Ultrasound of superficial lymph nodes,” European Journal of Radiology, vol. 58, no. 3, pp. 345–359, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. E. W. H. To, W. M. Tsang, J. Cheng et al., “Is neck ultrasound necessary for early stage oral tongue carcinoma with clinically N0 neck?” Dentomaxillofacial Radiology, vol. 32, no. 3, pp. 156–159, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Knappe, M. Louw, and R. T. Gregor, “Ultrasonography-guided fine-needle aspiration for the assessment of cervical metastases,” Archives of Otolaryngology—Head and Neck Surgery, vol. 126, no. 9, pp. 1091–1096, 2000. View at Google Scholar · View at Scopus
  35. N. Anand, N. Chaudhary, M. K. Mittal, and R. Prasad, “Comparison of the efficacy of clinical examination, ultrasound neck and computed tomography in detection and staging of cervical lymph node metastasis in head and neck cancers,” Indian Journal of Otolaryngology and Head and Neck Surgery, vol. 59, no. 1, pp. 19–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. P. M. Som, “Lymph nodes of the neck,” Radiology, vol. 165, no. 3, pp. 593–600, 1987. View at Google Scholar
  37. A. Ahuja and M. Ying, “Sonography of neck lymph nodes. Part II: abnormal lymph nodes,” Clinical Radiology, vol. 58, no. 5, pp. 359–366, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Ahuja, M. Ying, S. F. Leung, and C. Metreweli, “The sonographic appearance and significance of cervical metastatic nodes following radiotherapy for nasopharyngaeal carcinoma,” Clinical Radiology, vol. 51, no. 10, pp. 698–701, 1996. View at Google Scholar
  39. T. S. Atula, M. J. Varpula, T. J. I. Kurki, P.-J. Klemi, and R. Grénman, “Assessment of cervical lymph node status in head and neck cancer patients: palpation, computed tomography and low field magnetic resonance imaging compared with ultrasound-guided fine-needle aspiration cytology,” European Journal of Radiology, vol. 25, no. 2, pp. 152–161, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. R. B. J. de Bondt, P. J. Nelemans, P. A. M. Hofman et al., “Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging,” European Journal of Radiology, vol. 64, no. 2, pp. 266–272, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Mashberg, “Toluidine blue,” Journal of the Canadian Dental Association, vol. 61, no. 11, pp. 922–944, 1995. View at Google Scholar · View at Scopus
  42. A. Gupta, M. Singh, R. Ibrahim, and R. Mehrotra, “Utility of toluidine blue staining and brush biopsy in precancerous and cancerous oral lesions,” Acta Cytologica, vol. 51, no. 5, pp. 788–794, 2007. View at Google Scholar · View at Scopus
  43. I. C. Martin, C. J. Kerawala, and M. Reed, “The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 85, no. 4, pp. 444–446, 1998. View at Google Scholar · View at Scopus
  44. D. Rosenberg and S. Cretin, “Use of meta-analysis to evaluate tolonium chloride in oral cancer screening,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 67, no. 5, pp. 621–627, 1989. View at Google Scholar · View at Scopus
  45. J. J. Sciubba, “Improving detection of precancerous and cancerous oral lesions: computer-assisted analysis of the oral brush biopsy,” Journal of the American Dental Association, vol. 130, no. 10, pp. 1445–1457, 1999. View at Google Scholar · View at Scopus
  46. C. Scheifele, A.-M. Schmidt-Westhausen, T. Dietrich, and P. A. Reichart, “The sensitivity and specificity of the OralCDx technique: evaluation of 103 cases,” Oral Oncology, vol. 40, no. 8, pp. 824–828, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Scully, J. V. Bagan, C. Hopper, and J. B. Epstein, “Oral cancer: current and future diagnostic techniques,” American Journal of Dentistry, vol. 21, no. 4, pp. 199–209, 2008. View at Google Scholar · View at Scopus
  48. J. Handschel, D. Öz, N. Pomjanski et al., “Additional use of DNA-image cytometry improves the assessment of resection margins,” Journal of Oral Pathology and Medicine, vol. 36, no. 8, pp. 472–475, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. B. G. Zimmermann and D. T. Wong, “Salivary mRNA targets for cancer diagnostics,” Oral Oncology, vol. 44, no. 5, pp. 425–429, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Mehrotra, M. Hullmann, R. Smeets, T. E. Reichert, and O. Driemel, “Oral cytology revisited,” Journal of Oral Pathology and Medicine, vol. 38, no. 2, pp. 161–166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. C. S. Betz, T. Makriniotis, H. Stepp et al., “Diagnosis of head & neck malignancy using fluorescence spectroscopy and imaging,” Head & Neck Oncology, vol. 1, supplement 1, article O4, 2009. View at Google Scholar
  52. H. Stepp, A. Johansson, C. S. Betz, and A. Leunig, “Fluorescence spectroscopy and fluorescence imaging for tissue diagnostics—principles and methods,” Head & Neck Oncology, vol. 1, supplement 1, article O3, 2009. View at Google Scholar
  53. B. D. Kulbersh, R. D. Duncan, J. S. Magnuson, J. B. Skipper, K. Zinn, and E. L. Rosenthal, “Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts,” Archives of Otolaryngology—Head and Neck Surgery, vol. 133, no. 5, pp. 511–515, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. M. A. A. Suhr, C. Hopper, L. Jones, J. G. D. George, S. G. Bown, and A. J. MacRobert, “Optical biopsy systems for the diagnosis and monitoring of superficial cancer and precancer,” International Journal of Oral and Maxillofacial Surgery, vol. 29, no. 6, pp. 453–457, 2000. View at Google Scholar · View at Scopus
  55. T. Upile, W. Jerjes, H. J. C. M. Sterenborg et al., “Head & neck optical diagnostics: vision of the future of surgery,” Head & Neck Oncology, vol. 1, article 25, 2009. View at Google Scholar · View at Scopus
  56. W. Jerjes, T. Upile, A. Petrie et al., “Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients,” Head & Neck Oncology, vol. 2, article 9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Ebenezar, S. Ganesan, P. Aruna, R. Muralinaidu, K. Renganathan, and T. R. Saraswathy, “Noninvasive fluorescence excitation spectroscopy for the diagnosis of oral neoplasia in vivo,” Journal of Biomedical Optics, vol. 17, no. 9, Article ID 97007-1, 2012. View at Google Scholar
  58. D. Shin, N. Vigneswaran, A. Gillenwater, and R. Richards-Kortum, “Advances in fluorescence imaging techniques to detect oral cancer and its precursors,” Future Oncology, vol. 6, no. 7, pp. 1143–1154, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Duraipandian, M. S. Bergholt, W. Zheng et al., “Real-time Raman spectroscopy for in vivo, online gastric cancer diagnosis during clinical endoscopic examination,” Journal of Biomedical Optics, vol. 17, no. 8, Article ID 081418, 2012. View at Google Scholar
  60. L. B. Lovat, K. Johnson, G. D. Mackenzie et al., “Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett's oesophagus,” Gut, vol. 55, no. 8, pp. 1078–1083, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. H. J. C. M. Sterenborg, M. J. H. Witjes, S. de Visscher, and A. Amelink, “Differential pathlength spectroscopy for diagnosis of head and neck cancer,” Head & Neck Oncology, vol. 1, supplement 1, article O7, 2009. View at Google Scholar
  62. B. W. Pogue, V. Krishnaswamy, A. Laughney, K. D. Paulsen, P. J. Hoopes, and P. B. G. Allende, “Spectral scatter scanning system for surgical margin detection,” Head & Neck Oncology, vol. 1, supplement 1, article O12, 2009. View at Google Scholar
  63. C. Conti, P. Ferraris, E. Giorgini, C. Rubini, S. Sabbatini, and G. Tosi :, “Microimaging FT-IR of head and neck tumours. The case of salivary glands,” Head & Neck Oncology, vol. 1, supplement 1, article O13, 2009. View at Google Scholar
  64. G. Bradley, E. W. Odell, S. Raphael et al., “Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma,” British Journal of Cancer, vol. 103, no. 9, pp. 1432–1442, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. F. Fend, M. R. Emmert-Buck, R. Chuaqui et al., “Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis,” American Journal of Pathology, vol. 154, no. 1, pp. 61–66, 1999. View at Google Scholar · View at Scopus
  66. B. L. Ziober, M. G. Mauk, E. M. Falls, Z. Chen, A. F. Ziober, and H. H. Bau, “Lab-on-a-chip for oral cancer screening and diagnosis,” Head & Neck, vol. 30, no. 1, pp. 111–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. A. D. King, “Multimodality imaging of head and neck cancer,” Cancer Imaging, vol. 7, no. A, pp. S37–S46, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. K. E. Rusthoven, M. Koshy, and A. C. Paulino, “The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor,” Cancer, vol. 101, no. 11, pp. 2641–2649, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. E. J. Mahoney and J. H. Spiegel, “Evaluation and management of malignant cervical lymphadenopathy with an unknown primary tumor,” Otolaryngologic Clinics of North America, vol. 38, no. 1, pp. 87–97, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. M. M. Hanasono, L. D. Kunda, G. M. Segall, G. H. Ku, and D. J. Terris, “Uses and limitations of FDG positron emission tomography in patients with head and neck cancer,” The Laryngoscope, vol. 109, no. 6, pp. 880–885, 1999. View at Google Scholar
  71. A. C. Kole, O. E. Nieweg, J. Pruim et al., “Detection of unknow occult primary tumors using positron emission tomography,” Cancer, vol. 82, no. 6, pp. 1160–1166, 1998. View at Google Scholar
  72. W. M. Mendenhall, A. A. Mancuso, J. T. Parsons, S. P. Stringer, and N. J. Cassisi, “Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site,” Head & Neck, vol. 20, no. 8, pp. 739–744, 1998. View at Google Scholar
  73. A. C. Kole, O. E. Nieweg, J. Pruim et al., “Detection of unknow occult primary tumors using positron emission tomography,” Cancer, vol. 82, no. 6, pp. 1160–1166, 1998. View at Google Scholar
  74. A. A. Safa, L. M. Tran, S. Rege et al., “The role of positron emission tomography in occult primary head and neck cancers,” The Cancer Journal From Scientific American, vol. 5, no. 4, pp. 214–218, 1999. View at Google Scholar
  75. E. di Martino, B. Nowak, H. A. Hassan et al., “Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings,” Archives of Otolaryngology—Head and Neck Surgery, vol. 126, no. 12, pp. 1457–1461, 2000. View at Google Scholar · View at Scopus
  76. K. M. Greven, D. W. Williams III, W. F. McGuirt Sr. et al., “Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer,” Head & Neck, vol. 23, no. 11, pp. 942–946, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Jungehülsing, K. Scheidhauer, M. Damm et al., “2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation,” Otolaryngology—Head and Neck Surgery, vol. 123, no. 3, pp. 294–301, 2000. View at Google Scholar · View at Scopus
  78. M. P. Stokkel, K. G. Moons, F. W. ten Broek, P. P. van Rijk, and G. J. Hordijk, “18 F-Fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer,” Cancer, vol. 86, no. 11, pp. 2370–2377, 1999. View at Google Scholar
  79. S. C. Rankin, “PET in face and neck tumours,” Cancer Imaging, vol. 6, no. A, pp. S89–S95, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. O. S. Aassar, N. J. Fischbein, G. R. Caputo et al., “Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors,” Radiology, vol. 210, no. 1, pp. 177–181, 1999. View at Google Scholar · View at Scopus
  81. M. Maeda, H. Kato, H. Sakuma, S. E. Maier, and K. Takeda, “Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck,” American Journal of Neuroradiology, vol. 26, no. 5, pp. 1186–1192, 2005. View at Google Scholar · View at Scopus
  82. M. Sumi, N. Sakihama, T. Sumi et al., “Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer,” American Journal of Neuroradiology, vol. 24, no. 8, pp. 1627–1634, 2003. View at Google Scholar · View at Scopus
  83. C. R. Habermann, P. Gossrau, J. Graessner et al., “Diffusion-weighted echo-planar MRI: a valuable tool for differentiating primary parotid gland tumors?” Rofo, vol. 177, no. 7, pp. 940–945, 2005. View at Google Scholar
  84. A. R. Padhani, “Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions,” Journal of Magnetic Resonance Imaging, vol. 16, no. 4, pp. 407–422, 2002. View at Publisher · View at Google Scholar · View at Scopus
  85. D. Ribatti, A. Vacca, and M. Presta, “The discovery of angiogenic factors: a historical review,” General Pharmacology, vol. 35, no. 5, pp. 227–231, 2000. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Folkman, “Angiogenesis in cancer, vascular, rheumatoid and other disease,” Nature Medicine, vol. 1, no. 1, pp. 27–31, 1995. View at Google Scholar · View at Scopus
  87. M. Atri, “New technologies and directed agents for applications of cancer imaging,” Journal of Clinical Oncology, vol. 24, no. 20, pp. 3299–3308, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. P. Carmeliet and R. K. Jain, “Angiogenesis in cancer and other diseases,” Nature, vol. 407, no. 6801, pp. 249–257, 2000. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Verhoef, J. H. W. de Wilt, and H. M. W. Verheul, “Angiogenesis inhibitors: perspectives for medical, surgical and radiation oncology,” Current Pharmaceutical Design, vol. 12, no. 21, pp. 2623–2630, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. T. E. Yankeelov and J. C. Gore, “Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples,” Current Medical Imaging Reviews, vol. 3, no. 2, pp. 91–107, 2009. View at Google Scholar
  91. C. Majós, C. Aguilera, M. Cos et al., “In vivo proton magnetic resonance spectroscopy of intraventricular tumours of the brain,” European Radiology, vol. 19, no. 8, pp. 2049–2059, 2009. View at Google Scholar
  92. D. A. Sanghvi, “Recent advances in imaging of brain tumors,” Indian Journal of Cancer, vol. 46, no. 2, pp. 82–87, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. A. A. K. A. Razek, L. G. Elsorogy, N. Y. Soliman, and N. Nada, “Dynamic susceptibility contrast perfusion MR imaging in distinguishing malignant from benign head and neck tumors: a pilot study,” European Journal of Radiology, vol. 77, no. 1, pp. 73–79, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. J. R. Griffiths, N. J. Taylor, F. A. Howe et al., “The response of human tumors to carbogen breathing, monitored by gradient-recalled echo magnetic resonance imaging,” International Journal of Radiation Oncology Biology Physics, vol. 39, no. 3, pp. 697–701, 1997. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Rijpkema, J. H. A. M. Kaanders, F. B. M. Joosten, A. J. van der Kogel, and A. Heerschap, “Effects of breathing a hyperoxic hypercapnic gas mixture on blood oxygenation and vascularity of head-and-neck tumors as measured by magnetic resonance imaging,” International Journal of Radiation Oncology Biology Physics, vol. 53, no. 5, pp. 1185–1191, 2002. View at Publisher · View at Google Scholar · View at Scopus